Restore Medical, a leader in interventional cardiology innovations, has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Designation for its pioneering ContraBand device. This designation underscores the potential of ContraBand to transform the treatment landscape for patients suffering from heart failure with reduced ejection fraction (HFrEF), who have not […]
Anumana, an AI-driven health technology leader and a portfolio company of nference, has announced significant advancements in pulmonary hypertension (PH) diagnosis through its latest study, revealing promising results for its investigational PH algorithm. The study, titled “An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension,” was published in the European Respiratory Journal, showcasing the […]
